Skip to main content
Premium Trial:

Request an Annual Quote

GenapSys to Offer Twist Bioscience Library Prep, Target Enrichment Products

NEW YORK — GenapSys said on Monday that it has signed an agreement to offer Twist Bioscience's library preparation and target enrichment products to customers of its portable DNA sequencing system.

GenapSys launched its lunchbox-sized electronic sequencer, which uses microfluidic CMOS chips and has a list price of $10,000, in late 2019.

Under the terms of the deal, Redwood City, California-based GenapSys will begin integrating the Twist products into its portfolio in the second quarter. Additional terms were not disclosed.

"This OEM collaboration with GenapSys provides an ideal option for research laboratories, government organizations and sequencing providers, including healthcare facilities, to get access to our assays on GenapSys distributed sequencers," Emily Leproust, cofounder and CEO of San Francisco-based Twist, said in a statement. "With the distributed nature of the GenapSys high accuracy and affordable sequencer, there is the potential for wider adoption [of our products], benefitting a greater number of researchers and clinicians."

Earlier this month, GenapSys raised up to $75 million in debt financing and inked deals with more than 25 distributors worldwide. Twist, meanwhile, recently priced a $130 million public offering of common stock, which it expects to close today.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.